Kirschbaum KM - Search Results

1

Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection.

Kirschbaum KM, Müller MJ, Zernig G, Saria A, Mobascher A, Malevani J, Hiemke C. Kirschbaum KM, et al. Clin Chem. 2005 Sep;51(9):1718-21. doi: 10.1373/clinchem.2005.049809. Clin Chem. 2005. PMID: 16120951 No abstract available.

2

Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects.

Kirschbaum KM, Müller MJ, Malevani J, Mobascher A, Burchardt C, Piel M, Hiemke C. Kirschbaum KM, et al. World J Biol Psychiatry. 2008;9(3):212-8. doi: 10.1080/15622970701361255. World J Biol Psychiatry. 2008. PMID: 17853280

3

Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice.

Kirschbaum KM, Uhr M, Holthoewer D, Namendorf C, Pietrzik C, Hiemke C, Schmitt U. Kirschbaum KM, et al. Neuropharmacology. 2010 Nov;59(6):474-9. doi: 10.1016/j.neuropharm.2010.06.010. Epub 2010 Jul 3. Neuropharmacology. 2010. PMID: 20599439

4

Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.

Holthoewer D, Kirschbaum KM, Frisch J, Hiemke C, Schmitt U. Holthoewer D, et al. Among authors: kirschbaum km. Pharmacopsychiatry. 2013 Jul;46(5):175-80. doi: 10.1055/s-0033-1347176. Epub 2013 Jun 4. Pharmacopsychiatry. 2013. PMID: 23737243

5

Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice.

Kirschbaum KM, Henken S, Hiemke C, Schmitt U. Kirschbaum KM, et al. Behav Brain Res. 2008 Apr 9;188(2):298-303. doi: 10.1016/j.bbr.2007.11.009. Epub 2007 Nov 21. Behav Brain Res. 2008. PMID: 18164477

6

Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.

Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I. Gründer G, et al. Among authors: kirschbaum km. Am J Psychiatry. 2008 Aug;165(8):988-95. doi: 10.1176/appi.ajp.2008.07101574. Epub 2008 Apr 1. Am J Psychiatry. 2008. PMID: 18381901

7

Rotarod impairment: catalepsy-like screening test for antipsychotic side effects.

Kirschbaum KM, Hiemke C, Schmitt U. Kirschbaum KM, et al. Int J Neurosci. 2009;119(10):1509-22. doi: 10.1080/00207450902984002. Int J Neurosci. 2009. PMID: 19922371

8

In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes.

Schmitt U, Kirschbaum KM, Poller B, Kusch-Poddar M, Drewe J, Hiemke C, Gutmann H. Schmitt U, et al. Among authors: kirschbaum km. Pharmacol Biochem Behav. 2012 Aug;102(2):312-20. doi: 10.1016/j.pbb.2012.04.002. Epub 2012 Apr 15. Pharmacol Biochem Behav. 2012. PMID: 22525746

9

Liquid chromatography-tandem mass spectrometry detection of the quaternary ammonium compound mebezonium as an active ingredient in t61.

Kirschbaum KM, Grellner W, Rochholz G, Musshoff F, Madea B. Kirschbaum KM, et al. J Anal Toxicol. 2011 Mar;35(2):124-8. doi: 10.1093/anatox/35.2.124. J Anal Toxicol. 2011. PMID: 21396233

10

Another suicide using the veterinary drug T61 and distribution of drugs in the body.

Musshoff F, Kirschbaum KM, Madea B. Musshoff F, et al. Among authors: kirschbaum km. J Anal Toxicol. 2013 Apr;37(3):186. doi: 10.1093/jat/bks140. Epub 2013 Jan 27. J Anal Toxicol. 2013. PMID: 23358154 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters